Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00680355 · ClinicalTrials.gov registry record · NA

Bioavailability of Golden Rice Carotenoids in Humans

A NA study of Healthy, sponsored by Tufts University.

Completed
Registry status
NA
Development phase
14
Enrollment target
1
Study location

NCT00680355: Completed NA study of Healthy, sponsored by Tufts University.

NCT00680355 is a NA study of Healthy that has completed, run by Tufts University. The registered enrollment target is 14 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00680355, a NA study of Healthy, has completed, sponsored by Tufts University.

COMPLETED
Registry status
NA
Development phase
14 participants
Enrollment target
1
Study location

Study Summary

This investigation protocol uses an isotope reference method to evaluate bioavailability of ß-C in rice and its bioconversion to vitamin A. A well-nourished population will be fed hydroponically grown Golden Rice containing \~ 1 mg of β-carotene at day 8 after a reference dose of vitamin A at day 1. The blood samples will be collected up to 33 days after the doses. The absorption kinetics will be determined by tracking both vitamin A and β-carotene in human serum. Blood responses to Golden Rice β-carotene will be determined and evaluated. The vitamin A value of Golden Rice can thus be quantitatively determined.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT golden rice
  • DIETARY_SUPPLEMENT corn oil 0g
  • DIETARY_SUPPLEMENT corn oil 10g
  • DIETARY_SUPPLEMENT coren oil 5 g

Study Locations (1)

Massachusetts

  • USDA Human Nutrition Research Center on Aging at Tufts Uni - Boston

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2004-08
Est. Completion 2012-08
Phase NA
Tufts University

163 total trials

What the finished NCT00680355 record still lists

NCT00680355 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 4 interventions - of which golden rice is the first listed.

NCT00680355 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00680355 about?

NCT00680355 is a clinical study titled "Bioavailability of Golden Rice Carotenoids in Humans". This investigation protocol uses an isotope reference method to evaluate bioavailability of ß-C in rice and its bioconversion to vitamin A. A well-nourished population will be fed hydroponically grown Golden Rice containing \~ 1 mg of β-carotene at day 8 after a reference dose of vitamin A at day 1...

What is the current status of trial NCT00680355?

This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2004-08. Estimated completion is 2012-08.

What conditions does trial NCT00680355 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT00680355?

The interventions under investigation include: golden rice (DIETARY_SUPPLEMENT), corn oil 0g (DIETARY_SUPPLEMENT), corn oil 10g (DIETARY_SUPPLEMENT), coren oil 5 g (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00680355?

This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00680355 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00680355's enrollment target sits among peer trials

14 974th of 1090 higher than 106 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02523092 · 14 participants · Phase 4

    Use of CXCL9 as a Biomarker of Acthar Efficacy

  • NCT04263285 · 14 participants · NA

    Treatment of Depression Post-SCI

  • NCT04743271 · 14 participants · NA

    Food and Circadian Timing

  • NCT05065671 · 14 participants · Phase 1

    Microbiome Derived Metabolism and Pharmacokinetics

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00680355, the US trial registry maintained by the National Library of Medicine. NCT00680355 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.